-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Multiple Myeloma: Clinical Challenges for the Community Clinician

Sponsor: Bristol Myers Squibb, Janssen, Sanofi, Karyopharm, and Legend.
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Diseases, Study Population
Friday, December 8, 2023: 11:00 AM-2:00 PM
Marriott Grand Ballroom 5-6 (Marriott Marquis San Diego Marina)
Chair:
Ola Landgren, MD, Sylvester Comprehensive Cancer Center, University of Miami
Disclosures:
Landgren: Merck: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Membership on independent data monitoring committees; Amgen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Membership on independent data monitoring committees; Takeda: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Membership on independent data monitoring committees; Janssen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Membership on independent data monitoring committees; Celgene: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Membership on independent data monitoring committees; Adaptive: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Membership on independent data monitoring committees; Theradex: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Membership on independent data monitoring committees.
Speakers:
Luciano Costa, MD, PhD, University of Alabama at Birmingham and Nisha S. Joseph, MD, Winship Cancer Institute of Emory University
Disclosures:
Costa: AbbVie: Honoraria, Research Funding; Amgen: Consultancy, Honoraria, Research Funding; BMS: Consultancy, Honoraria, Research Funding; Pfizer: Consultancy, Honoraria; Janssen: Consultancy, Honoraria, Research Funding; Adaptive biotechnologies: Consultancy, Honoraria; Genentech: Research Funding. Joseph: BMS: Honoraria; Janssen Oncology: Consultancy.
On Demand program will be available here January 8, 2024.

This 90-minute interactive symposium will feature a panel of experts evaluating the intricacies of care for patients with multiple myeloma through a series of challenging clinical cases. They will provide expert guidance and real-world perspectives related to optimizing outcomes at each phase of the treatment journey. Attendees can participate in interactive case challenges and engage directly with the expert panel in a closing Q&A session.